Purdue Pharma L.P., A Leading Pharmaceutical Company extends its Infrastructure Transformation contract with HCL
business services, custom application services, it infrastructure, enterprise application services, enterprise transformation services.
- Atlanta, GA (1888PressRelease) June 21, 2014 - HCL Technologies Ltd. (HCL), a global IT services provider, today announced that its customer, Purdue Pharma L.P, a leading pharmaceutical company has extended its end-to-end IT Infrastructure Management engagement with HCL, marking an important milestone for the strategic partnership signed in year 2010.
Under the terms of new agreement, HCL will expand collaboration with Purdue on their ongoing companywide IT and infrastructure management undertaking. This will include extended support on existing projects such as data center management as well as new assignments such as virtualization, backup transformation and future product rollouts. HCL will enable establishment and adoption of new systems and technologies by providing unified service aggregation and management across their servers, network, messaging, database, storage and backup. HCL will also render service desk and remote desktop services for all US offices of Purdue from its North Carolina based delivery center. With capacity for more than 1000 seats, HCL's North Carolina center is one of the key hubs for delivering information technology, infrastructure management and business process services to its global clients.
"We are pleased to expand our relationship with HCL for infrastructure managed services, service desk and security. This partnership has improved our ability to deliver cost effective and innovative solutions to support our business," said Larry A. Pickett, Jr., Vice President and Chief Information Officer at Purdue.
Vinod Chandran, Executive Vice President and Head of Infrastructure Services (North America), HCL said, "It is gratifying to see that Purdue continues to see the value we bring to this partnership and recognizes our efforts in taking this relationship beyond the contract. Through our pioneering service offerings and outcome-based business model, we are committed to delivering real-time, relevant business value to Purdue to transform their infrastructure and architecture and help them keep pace with changing business demands."
With over 23 years of industry experience in the infrastructure services space, HCL currently serves more than 250 clients across the globe and manages the infrastructure environment for four of the top seven pharmaceutical companies worldwide. HCL's infrastructure services practice continues to be the largest and the fastest growing business for the company and represents more than 30 percent of HCL's total revenues. The company recently announced a landmark global infrastructure management services engagement with one of the world's leading healthcare companies.
About Purdue Pharma L.P.
Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on chronic pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.
About HCL Technologies
HCL Technologies is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses. Since its emergence on global landscape after its IPO in 1999, HCL has focused on 'transformational outsourcing', underlined by innovation and value creation, offering an integrated portfolio of services including software-led IT solutions, remote infrastructure management, engineering and R&D services and Business services. HCL leverages its extensive global offshore infrastructure and network of offices in 31 countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare & Life sciences. HCL takes pride in its philosophy of 'Employees First, Customers Second' which empowers its 90,190 transformers to create real value for the customers. HCL Technologies, along with its subsidiaries, had consolidated revenues of US$ 5.2 billion, as on 31st March 2014 (on
LTM basis). For more information, please visit www.hcltech.com.
HCL Forward-looking Statements
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward looking statements, including but not limited to the statements containing the words 'planned', 'expects', 'believes',' strategy', 'opportunity', 'anticipates', 'hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, Business Process Outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost effective and timely manner, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry.
There can be no assurance that the forward looking statements made herein will prove to be accurate, a
nd issuance of such forward looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward looking statements made herein are based on information presently available to the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam